本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Stoke Therapeutics, Inc.

29.60
+0.57001.96%
盤後29.600.00000.00%19:30 EDT
成交量:50.04萬
成交額:1,475.04萬
市值:19.10億
市盈率:-8.88
高:29.70
開:29.38
低:29.01
收:29.03
52周最高:40.22
52周最低:20.32
股本:6,452.62萬
流通股本:4,901.27萬
量比:0.81
換手率:1.02%
股息:- -
股息率:- -
每股收益(TTM):-3.3325
每股收益(LYR):-0.1163
淨資產收益率:-61.10%
總資產收益率:-35.87%
市淨率:5.53
市盈率(LYR):-254.60

資料載入中...

2026/08/14

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/13

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/06

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/03

重要事件披露

Form 8-K - Current report
2026/08/03

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/08/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/03

重要事件披露

Form 8-K - Current report
2026/08/03

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/07/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/30

重要事件披露

Form 8-K - Current report
2026/06/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/04

重要事件披露

Form 8-K - Current report
2026/05/18

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/15

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/05/08

重要事件披露

Form 8-K - Current report
2026/05/08

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]